10x Genomics enters multi-project research agreement with Fred Hutchinson Cancer Center
TXG 10x Genomics Inc
$77.24 +1.49%
View chart & analysis → - 110x Genomics has signed a multi-project research agreement with the Fred Hutchinson Cancer Center.
- 2Both parties will conduct two studies to generate clinical evidence for tumor diagnosis.
- 3Lawrence Fong will lead this collaborative research.
So what's the key point?
10x Genomics has decided to research ways to diagnose cancer together with a cancer center. Through this collaboration, research will be conducted to create the evidence needed for cancer diagnosis.
Source Pharmaceutical Business Review · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.